Citric Buffered Normal Saline
RxNorm Crosswalk NDC 72000-030

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Citric Buffered Normal Saline (NDC 72000-030) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 4 unique RxNorm concepts. By anchoring Nabriva Therapeutics Us, Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCD
15 mL lefamulin 10 mg/ML Injection
PSN
Xenleta 150 mg in 15 mL Injection
SCD
Lefamulin 600 mg Oral Tablet
PSN
Xenleta 600 mg Oral Tablet
SCDPrescribable
Featured Concept

15 ML lefamulin 10 MG/ML Injection
(RxCUI 2198948)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Mapped Terms
PSNPrescribable
lefamulin 150 MG in 15 ML Injection
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
SYPrescribable
lefamulin 150 MG per 15 ML Injection
Synonym
Synonym of another TTY, given for clarity.
PSNPrescribable
Featured Concept

Xenleta 150 MG in 15 ML Injection
(RxCUI 2198953)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Mapped Terms
SBDPrescribable
15 ML lefamulin 10 MG/ML Injection [Xenleta]
Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
SYPrescribable
15 ML Xenleta 10 MG/ML Injection
Synonym
Synonym of another TTY, given for clarity.
SYPrescribable
Xenleta 150 MG per 15 ML Injection
Synonym
Synonym of another TTY, given for clarity.
SCDPrescribable
Featured Concept

lefamulin 600 MG Oral Tablet
(RxCUI 2198961)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

Mapped Terms
PSNPrescribable
lefamulin 600 MG Oral Tablet
Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
PSNPrescribable
Featured Concept

Xenleta 600 MG Oral Tablet
(RxCUI 2198966)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Mapped Terms
SBDPrescribable
lefamulin 600 MG Oral Tablet [Xenleta]
Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name
SYPrescribable
Xenleta 600 MG Oral Tablet
Synonym
Synonym of another TTY, given for clarity.

Understanding RxNorm Mapping for Citric Buffered Normal Saline

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 72000-030 to RxCUI 2198948, 2198953, 2198961, 2198966, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.

* Please review the full disclaimer at the bottom of this page.